pds0101

Vaccineexperimental

Clinical trial activity

3 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Mar 9, 2020 (NCT04287868)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07090174Phase 2Oct 20, 2025Cornell University, Emory University, National Cancer Institute (NCI), University of California, San Diego, University of Maryland, University of Puerto Rico, University of South Florida, Yeshiva University
NCT04260126Phase 2Jun 30, 2020Merck, PDS Biotechnology Corp.
NCT04287868Phase 1/Phase 2 (Phase 2)Mar 9, 2020National Cancer Institute (NCI)
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government2112020
Cornell UniversityAcademic/Hospital1112025
Emory UniversityAcademic/Hospital1012025
MerckFor profit1012020
PDS Biotechnology Corp.For profit1112020
University of California, San DiegoAcademic/Hospital1012025
University of MarylandAcademic/Hospital1012025
University of Puerto RicoAcademic/Hospital1012025
University of South FloridaAcademic/Hospital1012025
Yeshiva UniversityAcademic/Hospital1012025
10 organizations
Page 1 / 1